Orville G. Kolterman
Direttore/Membro del Consiglio presso American Diabetes Association Research Foundation, Inc.
Posizioni attive di Orville G. Kolterman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| National Institute of Diabetes & Digestive & Kidney Diseases | Corporate Officer/Principal | - | - |
GlySens, Inc.
 GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 27/10/2011 | - |
| American Diabetes Association Research Foundation, Inc. | Direttore/Membro del Consiglio | 27/10/2011 | - |
Storia della carriera di Orville G. Kolterman
Precedenti posizioni note di Orville G. Kolterman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | 29/01/2019 |
| University of California San Diego | Corporate Officer/Principal | 01/01/1983 | 01/01/1992 |
| The University of Colorado School of Medicine | Corporate Officer/Principal | 01/01/1978 | 01/01/1983 |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Presidente | - | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1992 | - |
| Consigliere Generale | 01/01/1992 | - |
Formazione di Orville G. Kolterman
| Stanford University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| National Institute of Diabetes & Digestive & Kidney Diseases | Government |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Health Technology |
| American Diabetes Association Research Foundation, Inc. |
- Borsa valori
- Insiders
- Orville G. Kolterman
- Esperienza
